bioMerieux (OTCMKTS:BMXMF) Shares Gap Down – Here’s Why
by Tristan Rich · The Markets DailybioMerieux (OTCMKTS:BMXMF – Get Free Report)’s stock price gapped down prior to trading on Monday . The stock had previously closed at $120.19, but opened at $103.41. bioMerieux shares last traded at $103.41, with a volume of 87 shares changing hands.
Analysts Set New Price Targets
Separately, BNP Paribas Exane cut shares of bioMerieux to a “neutral” rating in a report on Wednesday, January 28th. Two analysts have rated the stock with a Hold rating, According to MarketBeat.com, bioMerieux currently has an average rating of “Hold”.
Read Our Latest Report on BMXMF
bioMerieux Stock Performance
The company has a quick ratio of 1.48, a current ratio of 2.39 and a debt-to-equity ratio of 0.08. The firm has a fifty day simple moving average of $112.18 and a two-hundred day simple moving average of $122.05.
About bioMerieux
bioMérieux is a global leader in in vitro diagnostics, specializing in the development, manufacture and distribution of diagnostic solutions that determine the source of disease and contamination to improve patient health and ensure consumer safety. The company’s product portfolio encompasses a broad range of assays and instruments for microbiological and immunoassay testing, including molecular diagnostics for infectious diseases, immunoassays for autoimmune and oncology markers, and traditional microbial identification and antimicrobial susceptibility testing.